OMERS Administration Corp’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-136,300
Closed -$94K 547
2020
Q4
$94K Buy
+136,300
New +$290K ﹤0.01% 252

Other funds holding BMY.RT

OMERS Administration Corp's BMY.RT Position: Q1 2021 in Review

OMERS Administration Corp sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 136,300 shares — an estimated $94K sold.

OMERS Administration Corp first reported a position in BMY.RT in Q4 2020 and held it in 1 quarter. The position peaked at $94K in Q4 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • OMERS Administration Corp reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • OMERS Administration Corp sold 136,300 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $94K.
  • OMERS Administration Corp first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2020 and held it in 1 quarter.
  • OMERS Administration Corp's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $94K in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on OMERS Administration Corp's 13F filing for Q1 2021, filed 14 May 2021.